Related Experiment Videos

Tumoricidal activity and cytokine secretion by tumor-infiltrating macrophages

M J Brunda1, V Sulich, R B Wright

  • 1Department of Oncology, Roche Research Center, Hoffmann-La Roche Inc., Nutley NJ 07110.

Insights

Tumor-infiltrating macrophages (TIM) from lung metastases respond to biological response modifiers (BRM) similarly to alveolar macrophages (AM), showing potential for cancer immunotherapy.

Area of Science:

  • Immunology
  • Cancer Biology
  • Cell Biology

Background:

  • Macrophages are crucial immune cells with diverse functions.
  • Different macrophage populations exhibit distinct responses to stimuli.
  • Understanding macrophage behavior is key for developing cancer therapies.

Purpose of the Study:

  • To compare the tumoricidal activity and cytokine secretion of macrophages from different anatomical sites.
  • To investigate the effects of biological response modifiers (BRM) on peritoneal macrophages (PM), alveolar macrophages (AM), and tumor-infiltrating macrophages (TIM).

Main Methods:

  • Murine macrophages (PM, AM, TIM) were isolated from B16F10 melanoma.
  • Macrophages were stimulated in vitro with BRM: recombinant murine interferon gamma (rMuIFN-gamma), lipopolysaccharide (LPS), and muramyl dipeptide (MDP).
  • Tumoricidal activity, interleukin-1 (IL-1), and tumor necrosis factor (TNF) secretion were measured.

Main Results:

  • PM showed increased cytotoxicity with LPS or rMuIFN-gamma.
  • AM and TIM required combinations of BRM (rMuIFN-gamma + LPS or rMuIFN-gamma + MDP) for tumoricidal induction.
  • TIM exhibited impaired TNF secretion, potentially due to isolation methods.

Conclusions:

  • Tumor-infiltrating macrophages from lung metastases share functional similarities with alveolar macrophages.
  • TIM respond to BRM in a manner comparable to AM regarding tumoricidal activity and cytokine secretion.
  • These findings suggest potential therapeutic strategies targeting macrophage function in cancer.

Related Concept Videos